- Oops!Something went wrong.Please try again later.
Yahoo Finance’s Emily McCormic breaks down latest jobless claims numbers.
Yahoo Finance’s Emily McCormic breaks down latest jobless claims numbers.
The "Proton Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Trinseo (NYSE: TSE), a global materials company and manufacturer of plastics, latex binders, and synthetic rubber announced that it can now supply recycled polystyrene (rPS) for food contact applications with the launch of the first yogurt pot integrating rPS, now on shelves in France.
Aceto Expands Life Science Manufacturing with Acquisition of Finar Limited
SOURCEPOINT MAKES SERIES OF SENIOR APPOINTMENTS AS IT CONTINUES RAPID GROWTH
Keystone Agency Investors Secures $105 Million Senior Credit Facility with Madison Capital.
Kinetic by Windstream, a long-trusted community partner for high-speed internet, announced today it is creating a new engineering and fiber construction organization to manage its broadband expansion across 18 states. The company plans to add nearly 1,000 jobs.
Bill forces death row inmates to choose between firing squad and electric chair
Crown Place VCT PLCInterim Management StatementLEI Code: 213800SYIQPA3L3T1Q68 IntroductionI am pleased to present Crown Place VCT PLC’s (the “Company”) interim management statement for the period from 1 January 2021 to 31 March 2021. Performance and dividendsThe Company’s unaudited net asset value (NAV) as at 31 March 2021 was £70.96 million or 31.59 pence per share (excluding treasury shares). After accounting for a dividend of 0.78 pence per share which was paid on 31 March 2021 to shareholders on the register on 5 March 2021 the NAV has increased by 1.24 pence per share (4.09%) since 31 December 2020. Fundraising and share issuesDuring the period from 1 January 2021 to 31 March 2021, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2020/21: DateNumber of shares issuedIssue price per share (including costs of issue)Net proceeds £’00026 February 202126,967,47931.7p to 32.0p8,414 The Company also issued the following shares under the dividend reinvestment scheme which are included in the net asset value figures for 31 March 2021 above: DateNumber of shares issuedIssue price per shareNet invested £’00031 March 2021976,92230.35 pence295 The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/CRWN. Share buy-backsDuring the period from 1 January 2021 to 31 March 2021, the Company purchased 1,304,353 shares for £388,000 including stamp duty, at an average price of 29.57 pence per share. All of the shares are to be held in treasury. It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders. It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit. PortfolioThe following investments have been made during the period from 1 January 2021 to 31 March 2021: New investments£’000ActivityThreadneedle Software Limited (T/A Solidatus)1,239Provider of data lineage software to enterprise customers in regulated sectors, which allows them to rapidly discover, visualise, catalogue and understand how data flows through their systemsTotal new investments1,239 Further investments£’000ActivityHealios Limited486Provider of an online platform delivering family centric psychological care primarily to children and adolescentsBlack Swan Data Limited262Predictive analytics for consumer brandsePatient Limited (T/A Raremark)46Online community connecting people affected by rare diseasesTotal further investments794 The following disposals were made during the period from 1 January 2021 to 31 March 2021: Portfolio CompanyCost£’000Proceeds£’000Shinfield Lodge Care Limited2,1404,580Active Lives Care Limited1,6202,874Ryefield Court Care Limited1,2752,374SBD Automotive Limited220379OmPrompt Holdings Limited153350Total 5,40810,557 In March 2021, the Company completed the sale of its three care homes for the elderly; Active Lives Care Limited, Ryefield Court Care Limited, and Shinfield Lodge Care Limited. The purpose-built residential care homes situated across the South of England, offer luxury living with all-inclusive service and an excellent level of care. The homes were trading at mature occupancy levels. The first investments in the homes were made over 5 years ago and the sale generated a 2.5x return on cost (including interest received), an excellent result for the Company. Top ten holdings as at 31 March 2021: InvestmentCarrying value£’000% of net asset valueActivityQuantexa Limited4,7686.7Network analytics platform to detect financial crimeProveca Limited3,5965.1UK based pharma company specialising in medicines for childrenChonais River Hydro Limited3,1144.4Owner and operator of a 2 MW hydro-power scheme in the Scottish HighlandsRadnor House School (TopCo) Limited2,7433.9Independent school for children aged 2-18The Evewell (Harley Street) Limited1,7282.4Operator of a women’s health centre focusing on fertilityGharagain River Hydro Limited1,6762.4Owner and operator of a 1 MW hydro-power scheme in the Scottish HighlandsPhrasee Limited1,6062.3AI platform that generates optimised marketing campaignsThreadneedle Software Holding Limited (T/A Solidatus)1,2391.7Provider of data lineage software to enterprise customers in regulated sectorHealios Limited1,0811.5Provider of an online platform delivering family centric psychological care primarily to children and adolescentsEgress Software Technologies Limited9961.4Encrypted email and file transfer service provider Material events and transactions after the period endAfter the period end, the Company had the following material investment transactions: Investment of £608,000 in a new portfolio company, an open sources API management platform that enables enterprises to manage their APIs through their lifecycle (from design to publishing to controlling access and security); andInvestment of £168,000 in an existing portfolio company, Panaseer Limited, a provider of cyber security services. Other than as described above, there have been no material events or transactions during the quarter and to the date of this announcement. Further informationFurther information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/CRWN. Penny Freer, Chairmancrownchair@albion.capital 17 May 2021 For further information please contact:Vikash HansraniOperations PartnerAlbion Capital Group LLPTelephone: 020 7601 1850
Birdwatchers in a flap over prominence of male birds compared to female counterparts
Met Office says 91% of May’s expected rain fell by Friday
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Commercial Hand Dryer Market Report. The global commercial hand dryer market by revenue is expected to grow at a CAGR of approx.New York, May 17, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Commercial Hand Dryer Market - Global Outlook and Forecast 2021-2026" - https://www.reportlinker.com/p06071901/?utm_source=GNW 8% during the period 2020–2026. The global market for commercial hand dryers is undergoing several transformations. The adoption of innovative commercial hand dryer products has increased among end-users worldwide, fueled by the rising emphasis on sustainable and smart infrastructure development such as infrastructure 4.0, along with IoT. Intensifying competition among key players has led to the introduction of innovative and advanced solutions in the market. Since the outbreak of the coronavirus pandemic across the world, there has been an increase in handwashing at homes, workplaces, and public spaces. This is because regular handwashing is one of the best weapons against the virus, which causes a flu-like respiratory illness that can prove to be fatal and spread rapidly among people across countries. Although there are hygiene norms at homes, it is critical in the public environment to promote proper hand drying solutions in toilets and washrooms to reduce the potential transmission of bacteria and viruses. The following factors are likely to contribute to the growth of the commercial hand dryer market during the forecast period: • Focus on Reducing Energy Consumption • Enhanced Focus on Hand Hygiene • Emphasis on Infrastructure Development • A shift toward Eco-friendly Technology The study considers the present scenario of the commercial hand dryer market and its market dynamics for the period 2020?2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. Global Commercial Hand Dryer Market Segmentation In terms of revenue, hot air hand dryers dominated the market with a share of over 51% in 2020. The segment is expected to record an incremental revenue of over USD 310 million during 2020?2026. The demand expects to grow rapidly in the APAC region owing to the rising hygiene concerns and the adoption of new technologies. The APAC region projects to grow at a CAGR of over 8% during the forecast period. While the application of hot air hand dryers is universal, increasing concerns over hygiene and bacterial infections are likely to hamper the commercial hand dryer market growth. With the growing popularity of jet air hand dryers, the segment accounted for over 48% in terms of units. The COVID-19 outbreak created turmoil in the market, which has slowed down the demand for hand dryers. Vendors are increasing awareness of hand dryers through a combination of direct advertising, niche targeting, trade shows, and holistic marketing. However, with the advent and rising popularity of digital and social media marketing, gaining customers has increased drastically. Commercial hand dryers accounted for a share of approx. 27% in terms of revenue and volume in 2020. The retail hand dryers market expects to grow at a CAGR of approx. 9% in APAC between 2020 and 2026. Expansion of airports, coupled with metro and railway station development, is a significant factor boosting the adoption of hand dryers. The demand for long-distance rail transport has already grown and is anticipated to grow as the rail network develops in Europe and Asia. Therefore, modernization of railways offers high scope for the growth of commercial hand dryers during the forecast period. The global commercial hands-under dryer segment expects to reach over USD 950 million by 2026. The use of these dryers is safe, which expect to drive their application during the forecast period. Although hands-under dryers are mostly conventional products, increased emphasis on innovations and technological advances influence the market growth. A major factor affecting the growth is the introduction of automatic sensor-based dryers with heat advances. Europe is expected to generate the highest revenue by 2026, followed by APAC and North America. A key strategy adopted by key players is the introduction of differentiated products and solutions for different application segments. Hence, companies strive to offer differentiated channels for distribution and a better product mix, thereby catering to target customers’ changing needs and requirements. Key manufacturers are offering and expanding their product line-up to launch innovative techniques, thereby gaining an edge over their market rivals. The hands-in hand dryer segment expects to project an absolute growth of 50% in Europe during 2020?2026 by unit sales. Hands-in dryers are comparatively higher than hands-under dryers; hence their preference is considerably increased in developed regions such as Europe and North America. The commercial hand dryer market by offline segment expects to witness an incremental revenue of over USD 600 million during 2020?2026. Vendors have promoted sales via retail stores such as specialty stores and electronic stores, although selling these devices online is increasing in recent years. The online segment in Europe is likely to reach over USD 57 million by 2026. Retail sales constituted over 92% of the distribution model in 2020. Vendors in countries such as the US primarily sell their finished products through dealers, distributors or the internet. In 2020, the retail segment was the largest revenue contributor to the global commercial hand dryer market. The online segment faces strong competition from the retail segment because of the established and growing retail network of manufacturers with mass orders, which has increased the visibility of these products on store shelves across the world. However, the online segment is witnessing high traction in the US and other APAC countries, particularly China and India. Product • Jet Air • Hot Air Operation • Hands-in Dryer • Hands-under Dryer Application • Education • Hospitality • Healthcare • Commercial Spaces • Corporate Spaces • Government Spaces • Industrial • Other Distribution • Offline o Dealers o Mass Market Players o Specialty Stores o Electronic Stores • Online Insights by Geography The Europe commercial hand dryer market expects to reach over USD 668 million by 2026. One of the primary reasons for the high adoption of commercial hand dryers among European households is increased per capita disposable income. The improving economy in several European countries has grown the disposable income in the population. Further, higher living standards across societies in the region and the favorable trade environment are expected to drive the Europe commercial hand dryer market share. In addition, end-users in these countries are known to have a high annual savings ratio. European customers, especially Germans and the British, realistically take advantage of retail discounting fueled by retailers’ destocking as they are willing to pay more for a lavish lifestyle. This can increase the footfall in the hospitality sector, thereby fueling the demand for hand dryers in the hospitality and corporate sectors during the forecast period. By Geography • North America o US o Canada • Europe o UK o Germany o France o Spain o Italy o Nordic o Benelux • APAC o China o Japan o South Korea o India o Australia • Latin America o Brazil o Mexico o Argentina • Middle East & Africa o Saudi Arabia o South Africa o Turkey o UAE Insights by Vendors Excel Dryer, Mitsubishi Electric, Mediclinics, TOTO, and Rexnord are the prominent vendors in the commercial hand dryer market. The market has witnessed the entry of several vendors due to the high demand and the increased scope for innovations. These players compete on various factors such as price, operational efficiency, quality, eco-friendliness, and variety. However, pricing and operational efficiency are set to become a major criterion for competition among players to gain an edge over other vendors in the market. Further, the growth of vendors depends on GDP growth and urban development. Therefore, to attain sustainability, expansion into other geographies and revival of domestic demand are essential factors for market vendors. Vendors can enhance their revenue and profitability by practicing sound production techniques that minimize product costs and mitigate associated risks. As the market demand is mainly met via dealers and distributor networks, vendors can consider developing strategic channels with prominent commercial infrastructure construction players to gain a stronghold on existing demand in the respective markets. Prominent Vendors • Excel Dryer • Mitsubishi Electric • Mediclinics • TOTO • Rexnord (World Dryer) Other Prominent Vendors • Aike • ASI Group • Askon Hygiene Products • Bobrick • Bardley Corporation • Comac Corporation • DIHOUR • Dyson • Electrostar • Hokwang Industries • JVD • Jaguar Group • Jie Da Electrical • Metlam Australia • Palmer Fixture • SPL • Stiebel Eltron • Lovair • Toshi Automatic Systems (TASPL) • Sloan Valve Company KEY QUESTIONS ANSWERED: 1. How big is the commercial hand dryer market? 2. What is the growth rate of the market? 3. Who are the key players in the commercial hand dryers market? 4. Who are the major end-users of commercial hand dryers? 5. Which region is likely to generate the highest revenue during the forecast period?Read the full report: https://www.reportlinker.com/p06071901/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
On the long walk to the gate it was clear that some passengers had neglected to take the Covid test. They will not be travelling today
Language barrier has always been a big problem for people who speak different languages. There are many translation apps trying to solve this problem, however, the language obstacles to people's remote communication has not yet been well resolved. It is impossible for a person to make a phone call to another one who speaks a different language that he totally does not understand. But iTourTranslator , which has various functions such as phone call translation, video call translation, conference translation, etc., has pushed way the barrier and made it a past story.
A powerful cyclonic system, Tauktae, is expected to make landfall in the Indian state of Gujarat late Monday after barrelling up the Arabian Sea in the Indian Ocean.
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a feasibility agreement with LTS Lohmann Therapie-Systeme AG (“LTS”), a leader in pharmaceutical oral thin films, to develop and manufacture a proprietary oral psilocybin thin film strip for the Company’s clinical and commercial initiatives to evaluate in mental illness, neurological and substance abuse disorders. “We are very excited to work with LTS, as one of the world’s largest innovators and suppliers of oral thin films, to develop our proprietary oral psilocybin thin film strip product for pharmaceutical use,” said Michael Frank, CEO of Revive. “Revive positioned itself as an innovator of novel uses and delivery forms of psilocybin, as a potential treatment for unmet medical needs. Revive, with our relationship with LTS, will be able to expedite its clinical and commercial ambitions with psilocybin as a pharmaceutical, globally.” Over the last twelve months, the Company has been focused on creating relationships and building a robust psilocybin-based product pipeline that includes novel uses, formulations, oral thin film delivery and biosynthetic forms of psilocybin. The Company collaborated with University of Wisconsin-Madison to develop an oral thin film technology and is engaged with North Carolina State University to develop a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform developed by Dr. Gavin Williams. Also, Revive is working with the University of Wisconsin to evaluate psilocybin as a potential treatment of methamphetamine use disorder and it recently submitted an application with the U.S. Food and Drug Administration ("FDA") to receive Orphan Drug Designation ("ODD") for psilocybin to treat traumatic brain injury, based in part of the research program acquired from PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF). There are a number of advantages and benefits of an orally dissolvable psilocybin thin film such as the rapid dissolving and onset of action to the bloodstream, the ease and convenience for patients to administer without the need of water, chewing or swallowing, the potential of improved therapeutic outcomes and efficacy for underserved diseases and disorders including the flexibility to create accurate dosing and tasteful options. “At LTS, we are unrelenting in our commitment to make life better for patients,” comments Bas van Buijtenen, CEO of LTS. “Under this agreement, we will deploy our full expertise and experience to the development of new therapeutic options in an area that fits perfectly with our strategic focus. The cooperation with Revive is an opportunity to demonstrate once again how LTS creates commercial value at every stage of development.” Under the terms of the Agreement, LTS shall perform certain formulation development of oral psilocybin thin films, to support preclinical studies for the product development, as well as GMP manufacturing of clinical trial supplies. Revive cautions that psilocybin is still under early-stage research and development and is not making any express or implied claims as to their success in the treatment of mental illness, neurological and substance abuse disorders or commercial viability. About LTS Lohmann Therapie-Systeme AG LTS Lohmann Therapie-Systeme AG is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) for the pharmaceutical industry. LTS’s commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 30 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Micro Array Patches for the transdermal delivery of large molecule, biological actives. Founded in 1984, LTS operates today from two sites in Andernach, Germany and West Caldwell, NJ, USA and a representative office in Shanghai, China. About Revive Therapeutics Ltd. Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit www.ReviveThera.com. For more information, please contact: Michael Frank Chief Executive Officer Revive Therapeutics Ltd. Tel: 1 888 901 0036 Email: email@example.com Website: www.revivethera.com Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of this release. Cautionary Statement This press release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Revive’s current belief or assumptions as to the outcome and timing of such future events. Forward looking information in this press release includes information with respect to the Company’s cannabinoids, psychedelics and infectious diseases programs. Forward-looking information is based on reasonable assumptions that have been made by Revive at the date of the information and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The foregoing statements expressly qualify any forward-looking information contained herein. Reference is made to the risk factors disclosed under the heading “Risk Factors” in the Company’s annual MD&A for the fiscal year ended June 30, 2020, which has been filed on SEDAR and is available under the Company’s profile at www.sedar.com.
Food blogger reveals how to get piping hot fries - and shows temperature difference
Follow below for all the latest updates from Washington and beyond
Apple Music has launched a new, higher quality tier that will allow people to listen to songs in “spatial audio”. The new update will make the entire catalogue available at lossless quality, Apple said. Users will also get access to spatial audio, which will let artists create songs in Dolby Atmos, allowing music to come from all around rather than just out of two different stereo channels.
After getting shellacked during the pandemic, consumer discretionary stocks are now back in vogue. If you're looking to take advantage of some unique opportunities in the consumer discretionary sector, keep reading to see why Etsy (NASDAQ: ETSY), Alibaba (NYSE: BABA), and Revolve Group (NYSE: RVLV) all look like promising picks. Unlike most of the consumer discretionary sector, Etsy, an online marketplace for crafts and handmade goods, saw its business soar during the pandemic, posting four straight quarters of triple-digit revenue growth.
The "Global Allergy Immunotherapies Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.